{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T16:05:57Z","timestamp":1774627557791,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-29729-1","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T07:55:38Z","timestamp":1765094138000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High doses of methylprednisolone causes substantial muscle loss with minimal impact on bone mass and architecture in C57BL\/6JRj and RjOrl:SWISS mice"],"prefix":"10.1038","volume":"16","author":[{"given":"Oliver Lassen","family":"Slavensky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik Duch","family":"Bromer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesper Skovhus","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarie","family":"Br\u00fcel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,7]]},"reference":[{"issue":"2","key":"29729_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1941874412458678","volume":"3","author":"LS Gensler","year":"2013","unstructured":"Gensler, L. S. Glucocorticoids: complications to anticipate and prevent. Neurohospitalist 3 (2), 92\u201397 (2013).","journal-title":"Neurohospitalist"},{"issue":"11","key":"29729_CR2","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","volume":"50","author":"L Fardet","year":"2011","unstructured":"Fardet, L., Petersen, I. & Nazareth, I. Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years. Rheumatol. (Oxford). 50 (11), 1982\u20131990 (2011).","journal-title":"Rheumatol. (Oxford)"},{"key":"29729_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/OARRR.S282606","volume":"13","author":"AO Kobza","year":"2021","unstructured":"Kobza, A. O. et al. Understanding and managing Corticosteroid-Induced osteoporosis. Open. Access. Rheumatol. 13, 177\u2013190 (2021).","journal-title":"Open. Access. Rheumatol."},{"issue":"6","key":"29729_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00198-019-04906-x","volume":"30","author":"G Adami","year":"2019","unstructured":"Adami, G. & Saag, K. G. Glucocorticoid-induced osteoporosis: 2019 concise clinical review. Osteoporos. Int. 30 (6), 1145\u20131156 (2019).","journal-title":"Osteoporos. Int."},{"issue":"10","key":"29729_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00198-007-0394-0","volume":"18","author":"E Canalis","year":"2007","unstructured":"Canalis, E. et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos. Int. 18 (10), 1319\u20131328 (2007).","journal-title":"Osteoporos. Int."},{"issue":"12","key":"29729_CR6","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/art.42646","volume":"75","author":"MB Humphrey","year":"2023","unstructured":"Humphrey, M. B. et al. 2022 American college of rheumatology guideline for the prevention and treatment of Glucocorticoid-Induced osteoporosis. Arthritis Rheumatol. 75 (12), 2088\u20132102 (2023).","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"29729_CR7","doi-asserted-by":"publisher","first-page":"707","DOI":"10.20945\/2359-3997000000566","volume":"66","author":"L Bandeira","year":"2022","unstructured":"Bandeira, L. & Lewiecki, E. M. Anabolic therapy for osteoporosis: update on efficacy and safety. Arch. Endocrinol. Metab. 66 (5), 707\u2013716 (2022).","journal-title":"Arch. Endocrinol. Metab."},{"key":"29729_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ejphar.2015.03.028","volume":"759","author":"T Komori","year":"2015","unstructured":"Komori, T. Animal models for osteoporosis. Eur. J. Pharmacol. 759, 287\u2013294 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"29729_CR9","doi-asserted-by":"crossref","unstructured":"Xavier, A., Toumi, H. & Lespessailles, E. Animal model for glucocorticoid induced osteoporosis: a systematic review from 2011 to 2021. Int. J. Mol. Sci.  23, 1 (2021).","DOI":"10.3390\/ijms23010377"},{"issue":"1","key":"29729_CR10","doi-asserted-by":"publisher","first-page":"R69","DOI":"10.1530\/JOE-17-0361","volume":"236","author":"CL Wood","year":"2018","unstructured":"Wood, C. L. et al. Animal models to explore the effects of glucocorticoids on skeletal growth and structure. J. Endocrinol. 236 (1), R69\u2013r91 (2018).","journal-title":"J. Endocrinol."},{"key":"29729_CR11","unstructured":"Johnson, M. Laboratory Mice and Rats (Labome, 2023)."},{"key":"29729_CR12","doi-asserted-by":"publisher","first-page":"36513","DOI":"10.1038\/srep36513","volume":"6","author":"A Ersek","year":"2016","unstructured":"Ersek, A. et al. Strain dependent differences in glucocorticoid-induced bone loss between C57BL\/6J and CD-1 mice. Sci. Rep. 6, 36513 (2016).","journal-title":"Sci. Rep."},{"issue":"Pt 1","key":"29729_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2818.1988.tb04609.x","volume":"151","author":"HJ Gundersen","year":"1988","unstructured":"Gundersen, H. J. The nucleator. J. Microsc. 151 (Pt 1), 3\u201321 (1988).","journal-title":"J. Microsc"},{"issue":"5","key":"29729_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S8756-3282(99)00212-4","volume":"25","author":"JS Thomsen","year":"1999","unstructured":"Thomsen, J. S., Mosekilde, L. & Gasser, J. A. Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats. Bone 25 (5), 561\u2013569 (1999).","journal-title":"Bone"},{"issue":"11","key":"29729_CR15","doi-asserted-by":"publisher","first-page":"e27482","DOI":"10.1371\/journal.pone.0027482","volume":"6","author":"K Henriksen","year":"2011","unstructured":"Henriksen, K. et al. Dissociation of bone resorption and bone formation in adult mice with a Non-Functional V-ATPase in osteoclasts leads to increased bone strength. PLOS ONE. 6 (11), e27482 (2011).","journal-title":"PLOS ONE"},{"issue":"1","key":"29729_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster, D. W. et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR histomorphometry nomenclature committee. J. Bone Min. Res. 28 (1), 2\u201317 (2013).","journal-title":"J. Bone Min. Res."},{"issue":"1","key":"29729_CR17","doi-asserted-by":"publisher","first-page":"12258","DOI":"10.1038\/s41598-021-91729-8","volume":"11","author":"MB Brent","year":"2021","unstructured":"Brent, M. B., Thomsen, J. S. & Br\u00fcel, A. Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice. Sci. Rep. 11 (1), 12258 (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"29729_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.steroids.2008.11.009","volume":"74","author":"M Herrmann","year":"2009","unstructured":"Herrmann, M. et al. The challenge of continuous exogenous glucocorticoid administration in mice. Steroids 74 (2), 245\u2013249 (2009).","journal-title":"Steroids"},{"issue":"1","key":"29729_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1530\/JOE-14-0508","volume":"224","author":"L Grahnemo","year":"2015","unstructured":"Grahnemo, L. et al. Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density. J. Endocrinol. 224 (1), 97\u2013108 (2015).","journal-title":"J. Endocrinol."},{"issue":"1","key":"29729_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12864-023-09523-x","volume":"24","author":"YH Jung","year":"2023","unstructured":"Jung, Y. H. et al. Characterization of a strain-specific CD-1 reference genome reveals potential inter- and intra-strain functional variability. BMC Genom. 24 (1), 437 (2023).","journal-title":"BMC Genom."},{"key":"29729_CR21","unstructured":"FDA, Guidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers, U.S.D.o.H.a.H. Services, Editor. 2005, Food and Drug Administration. Center for Drug Evaluation and Research (CDER)  (2005)."},{"issue":"12","key":"29729_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","volume":"72","author":"N Duru","year":"2013","unstructured":"Duru, N. et al. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann. Rheum. Dis. 72 (12), 1905\u20131913 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"29729_CR23","doi-asserted-by":"crossref","unstructured":"Lightman, S. L., Birnie, M. T. & Conway-Campbell, B. L. Dynamics of ACTH and cortisol secretion and implications for disease. Endocr. Rev. 41, 3  (2020).","DOI":"10.1210\/endrev\/bnaa002"},{"key":"29729_CR24","doi-asserted-by":"crossref","unstructured":"Marcotte, M. et al. Handling techniques to reduce stress in mice. J. Vis. Exp. 2021, 175 (2021).","DOI":"10.3791\/62593"},{"key":"29729_CR25","doi-asserted-by":"crossref","unstructured":"Amarasekara, D. S., Yu, J. & Rho, J. Bone loss triggered by the cytokine network in inflammatory autoimmune diseases. J. Immunol. Res.  2015,  832127 (2015).","DOI":"10.1155\/2015\/832127"},{"key":"29729_CR26","doi-asserted-by":"crossref","unstructured":"Webster, J. M. et al. Exploring the interface between inflammatory and therapeutic glucocorticoid induced bone and muscle loss. Int. J. Mol. Sci. 20, 22  (2019).","DOI":"10.3390\/ijms20225768"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29729-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29729-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29729-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:17:55Z","timestamp":1767622675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-29729-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,7]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["29729"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-29729-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,7]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"333"}}